Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 30,000 shares at $45.01 ($1.4M) on 2024-07-12, disclosed to the SEC on 2024-07-16.
Scheduled sale ($1.4M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.01 | 5,000 | $225K | 16.7% |
| 2 | $45.05 | 25,000 | $1.1M | 83.3% |
| Total | $45.04 avg | 30,000 | $1.4M | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $1.6M | — | Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |